Non‐severe COVID‐19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis

COVID-19 induces a hyperactive phenotype in circulating platelets

(2021) Shane P. Comer et al.   PLOS BIOLOGY

Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients

(2021) María Eugenia de la Morena-Barrio et al.   Scientific Reports

ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19

(2021) Soracha E. Ward et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

(2021) Michelle Sholzberg et al.   BMJ-British Medical Journal

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Incidence of venous thromboembolism in hospitalized patients with COVID‐19

(2020) Saskia Middeldorp et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection

(2020) Hanny Al-Samkari et al.   BLOOD

Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome

(2020) Elizabeth A Middleton et al.   BLOOD

Platelet Gene Expression and Function in COVID-19 Patients

(2020) Bhanu Kanth Manne et al.   BLOOD

Coagulopathy in COVID‐19

(2020) Toshiaki Iba et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Endothelial cells orchestrate COVID-19 coagulopathy

(2020) Jamie M O'Sullivan et al.   Lancet Haematology

Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID‐19): evidence of acute and sustained endothelial cell activation

(2020) Soracha E. Ward et al.   BRITISH JOURNAL OF HAEMATOLOGY

Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage

(2019) Chiao-Hsuan Chao et al.   PLoS Pathogens

Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia

(2017) Barry Kevane et al.   THROMBOSIS AND HAEMOSTASIS

Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia

(2016) Yan Yang et al.   Cellular & Molecular Immunology

Tissue Factor Pathway Inhibitor

(2015) Alan E. Mast   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation

(2013) Jason V. Baker et al.   Journal of the American Heart Association

Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study

(2011) K. WINCKERS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Regulation of TFPI function by protein S

(2009) T. M. HACKENG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Haemostatic Role of Tissue Factor Pathway Inhibitor

(2007) James T.B. Crawley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY